Video Head Impulse Test & Seasickness Susceptibility

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This a case control study on seasickness susceptibility. 86 healthy maritime personal were divided to seasickness susceptible and non susceptible groups based on a seasickness questionnaire (Golding) and motion sickness score. All subjects from both groups underwent video head impulse testing (vHIT). VHIT parameters - gain, asymmetry ect were compared between both groups.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02911402` - Motion Sickness on Astrolabe's Vessel
	Recruiting	`NCT05886660` - Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance	Phase 2

NCT number	NCT05657340
Study type	Interventional
Source	Medical Corps, Israel Defense Force
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2019
Completion date	May 1, 2020

Video Head Impulse Test and Seasickness Susceptibility

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms